WuXi Biologics specializes in biologics development and manufacturing, offering services such as drug substance manufacturing, analytical testing, cel...Read more
5,000 - 9,999
N/A
wuxibiologics.com
Partnership
Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by 6sense, used by WuXi Biologics
Are you looking for the decision-makers at WuXi Biologics? Get their email address, phone numbers, and other details from Linkedin or any website. Install and uncover WuXi Biologics’s employee details in less than 30 secs.
Sign-up for 6sense Revenue AI™ for Sales
To find emails, direct dials, and more for prospects across the web.
Sign Up TodayDiscover WuXi Biologics alternatives or similar companies to benchmark and competitors market analysis. Build a competitive intelligence sales and marketing strategy based on the data and stand out in the market.
Shenzhen QUANTONG Freight Company
1,000 - 4,999
Shenzhen
zencon.com.cn
N/A
N/A
Shenzhen Redaiyu Enterprise Consulting Management Co. Ltd.
0 - 9
Shenzhen
N/A
N/A
N/A
N/A
Warren National University
5,000 - 9,999
Cheyenne
wnuedu.com
N/A
N/A
N/A
West Seattle Elementary School
5,000 - 9,999
Seattle
westseattlees.seattleschools.org
N/A
N/A
Weilai Yicai Overseas Investment Fund Management Co. Ltd.
0 - 9
Shanghai
N/A
N/A
N/A
N/A
Sales prospecting needs to be timely and appropriate for the person and organization you are contacting. Following the most recent company news, alerts, and updates about the leads you are currently working on is the simplest and most convenient way to stay on top of them. Here are WuXi Biologics latest news, alerts and updates.
WuXi XDC raises $520m in IPO; eyes Singapore and China expansions
Having staged the IPO earlier this month, WuXi XDC says it intends to use the proceeds from the IPO to build facilities in Singapore and expand manufacturing capacity in China, pursue strategic partnerships and investment and acquisition opportunities ...
20 Nov 2023
WuXi XDC Sets IPO Price at Top of End of Range
A unit of Chinese contract drugmaker Wuxi Biologics set its initial public offering price at the top end of its guided range, indicating strong demand in a choppy year for listings in Hong Kong.
15 Nov 2023
WuXi Biologics' medical research unit eyes up to $471 million in Hong Kong IPO
The company, which is a joint venture between WuXi Biologics and WuXi STA that provides end-to-end contract services covering antibodies and other biologics intermediates, will issue 178.4 million shares priced at a maximum of HK$20.
7 Nov 2023
WuXi Biologics Unit Plans to Raise US$470.5M in Hong Kong IPO
By P.R. Venkat A WuXi Biologics unit plans to raise up to 3.68 billion Hong Kong dollars (US$470.5 million) through an initial public offering in one
6 Nov 2023
Explore frequently asked questions about WuXi Biologics’s business, including founding details, header quarters, information on technology stack, industry listing, and other details.
What is WuXi Biologics's official website?
The official website of WuXi Biologics is wuxibiologics.com You can find their contact number, email address, and headquarters by clicking here.
How many employees are working at WuXi Biologics?
What industry is WuXi Biologics in?
What is WuXi Biologics's tech stack?
Where are WuXi Biologics's headquarters?